Jacqueline Prevete, DPM
Foot & Ankle Surgery · New Hyde Park, NYNPI 1477997427
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,754 of the $22,454 with a category attached, or 79.1%. 26 manufacturers reported payments, led by Stryker at 39.0% of the total. Reporting peaked in 2023 at $6,177 and has fallen 71.5% since, to $1,762 in 2025. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $99.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9K
- Kerecis Limited$5K
- Gotham Surgical Solutions & Devices, Inc.$2K
- Arthrex$2K
- Smith+Nephew$1K
- Abbott$728
- plus $3K from 20 others
What the payments were for
- Travel & lodging$2,30010%
- Food & beverage$17,75479%
- Education$2,40011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 111 | $8,754 |
| Kerecis Limited | 10 | $4,940 |
| Gotham Surgical Solutions & Devices, Inc. | 7 | $2,286 |
| Arthrex | 6 | $1,520 |
| Smith+Nephew | 53 | $1,484 |
| Abbott | 5 | $728 |
| Inari Medical, Inc. | 2 | $378 |
| Paragon 28, Inc. | 3 | $296 |
| Organogenesis Inc. | 4 | $288 |
| Integra Lifesciences Corporation | 4 | $251 |
| Treace Medical Concepts, Inc. | 1 | $230 |
| Medtronic | 2 | $143 |
| Bioventus LLC | 3 | $136 |
| Nalu Medical, Inc. | 1 | $122 |
| Paratek Pharmaceuticals, Inc. | 1 | $121 |
| Lifenet Health | 1 | $113 |
| Averitas Pharma Inc. | 1 | $111 |
| GRT US Holding, Inc. | 1 | $104 |
| KCI USA, Inc. | 1 | $96 |
| Solventum Corporation | 1 | $96 |
| Tactile Systems Technology Inc | 1 | $89 |
| AbbVie | 1 | $67 |
| Polaris Technology Solutions LLC | 2 | $35 |
| Baxter Healthcare | 1 | $26 |
| Amgen | 1 | $22 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$11,498
- Kerecis Omega3 Marigen$8,366
- Kerecis Omega3 GraftGuide$3,892
- ALLOWRAP$1,459
- CITREFIX$925
- VARIAX$911
- HOFFMANN$885
- AUGMENT INJECTABLE$712
- 7 X 23MM CITRELOCK IMPLANT$687
- Kerecis SurgiClose$598
- Supera peripheral stent system$590
- PROstep$583
- FLEXBAND$578
- ORTHOLOC 2 LAPIFUSE$568
- ASNIS$557
- ANCHORAGE$395
- FLOWTRIEVER CATHETER, S$378
- CT THROMBECTOMY SYSTEM KIT$378
- N/A$326
- FLEXBAND MULTI KIT XL$309
How this compares
$22,454 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $3,384 |
| Ammonium Lactate | 12 | $172 |
| Doxycycline Hyclate | 11 | $95 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $48 |
| Meloxicam | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,484 | $3,38411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New Hyde Park
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$328K
- Stuart MogulNew York$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.